S&P 500

5.222,68

0,16%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
OncoCyte Corporation (OCX)
OncoCyte Corporation (OCX) Notícias

OCX

OncoCyte (OCX)

OncoCyte Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:OCX

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/06/2023	17:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:OCX	OncoCyte Corporation
09/06/2023	07:02	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:OCX	OncoCyte Corporation
19/05/2023	17:52	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:OCX	OncoCyte Corporation
01/05/2023	17:49	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	AMEX:OCX	OncoCyte Corporation
18/04/2023	19:50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	AMEX:OCX	OncoCyte Corporation
14/04/2023	17:32	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	AMEX:OCX	OncoCyte Corporation
12/04/2023	17:55	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:OCX	OncoCyte Corporation
07/04/2023	11:39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:OCX	OncoCyte Corporation
03/04/2023	07:02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	AMEX:OCX	OncoCyte Corporation
14/02/2023	13:34	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:OCX	OncoCyte Corporation
10/11/2022	18:50	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:OCX	OncoCyte Corporation
22/09/2022	18:39	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:OCX	OncoCyte Corporation
26/05/2022	17:15	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	AMEX:OCX	OncoCyte Corporation
18/04/2022	10:15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:OCX	OncoCyte Corporation
29/07/2021	17:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	AMEX:OCX	OncoCyte Corporation
07/07/2021	17:06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	AMEX:OCX	OncoCyte Corporation
15/06/2021	09:03	Business Wire	EchelonDx & Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offeri...	AMEX:OCX	OncoCyte Corporation
09/06/2021	07:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:OCX	OncoCyte Corporation
01/06/2021	17:26	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	AMEX:OCX	OncoCyte Corporation
28/05/2021	18:07	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	AMEX:OCX	OncoCyte Corporation
21/05/2021	17:11	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	AMEX:OCX	OncoCyte Corporation
08/03/2021	18:17	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	AMEX:OCX	OncoCyte Corporation
05/03/2021	15:44	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	AMEX:OCX	OncoCyte Corporation
05/03/2021	10:01	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...	AMEX:OCX	OncoCyte Corporation
01/03/2021	18:34	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	AMEX:OCX	OncoCyte Corporation
05/02/2021	08:07	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-3mef)	AMEX:OCX	OncoCyte Corporation
18/05/2020	07:07	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	AMEX:OCX	OncoCyte Corporation
18/03/2020	16:15	Edgar (US Regulatory)	Unknown (sec Staff)	AMEX:OCX	OncoCyte Corporation
14/02/2019	11:00	GlobeNewswire Inc.	BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias	AMEX:OCX	OncoCyte Corporation
14/08/2018	17:10	GlobeNewswire Inc.	OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate Developments	AMEX:OCX	OncoCyte Corporation